In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

ContraVir Pharmaceuticals Inc. Trade Record

NASDAQ:CTRV ContraVir Pharmaceuticals Inc stock gains 7.38% Exit Oct 19, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart CTRV Oct 18, 2018, priceSeries
About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. ContraVir Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Edison, New Jersey.

Trade Information
Trade Type
LONG
ReliabilityScore™
99.60
Entry Date
Oct 18, 2018
Entry Price
38.50
Sell Date
Oct 19, 2018
Sell Price
41.34
Net Gain
7.38%
Hold Time
1 Trading Days